COMMUNIQUÉS West-GlobeNewswire

Cyclacel Pharmaceuticals to Present at the Dawson James Small Cap Growth Conference
23/10/2018
BERKELEY HEIGHTS, N.J., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC, Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on [...]
Scythian Biosciences Makes Strategic Investment in Verano™ Holdings with $188 Million USD Transaction
23/10/2018
Scythian Invests USD$88 Million in Verano Class B Membership Units Scythian to Sell 3 Boys Farms in Share Exchange for USD$100 Million in Verano Class B Membership Units M&A Identified, Talent and Capital Aligned [...]
BeyondSpring Announces Top Line Positive Efficacy and Safety Data from Phase 2 Study 106 with Lead Asset, Plinabulin, for Chemotherapy-Induced Neutropenia Prevention
23/10/2018
Plinabulin Significantly Reduced Grade 3/4 CIN and Bone Pain When Combined with Neulasta, Compared to Neulasta Monotherapy, in Breast Cancer Patients Receiving High-Risk TAC Chemotherapy Company to Host Conference Call [...]
Tetraphase Pharmaceuticals Announces Positive Data from Post-Hoc Analysis of Phase 3 Trials Demonstrating Efficacy of XERAVA™ (eravacycline) in Obese and Renally Impaired Patients with Complicated Intra-Abdominal Infections
23/10/2018
WATERTOWN, Mass., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening [...]
Capital Senior Living Corporation Announces Release Date for Third Quarter 2018 Financial Results
23/10/2018
DALLAS, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (NYSE:CSU) will host a conference call with senior management to discuss the Company’s third quarter 2018 financial results. The call will be [...]
Alphatec to Report Third Quarter 2018 Financial Results on November 8, 2018
23/10/2018
CARLSBAD, Calif., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“Alphatec” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surgery solutions with a mission to improve patient lives through [...]
Reminder: C-RAD Web Presentation Interim Report Q3 2018
23/10/2018
Presentation of the report for the first three quarters of the fiscal year 2018: Date: Friday October 26, 2018 / kl. 13:00 CEST Venue: Online Presentation Topic: C-RAD Interim Report Q3 2018 Procedure: Please register [...]
CellaVision AB: Interim report January-September 2018
23/10/2018
Continued strong performance in all regions July 1-September 30, 2018 Net sales increased by 37 % to SEK 84.3 million (61.3). Organic growth increased to 33 % (-11). Operating profit increased to SEK 21.0 million (10.2 [...]
Rule 2.9 Announcement
23/10/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 23 October 2018 [...]
Interim Report January-September 2018
23/10/2018
Summary JULY-SEPTEMBER IN BRIEF PledPharma announces positive results from the Aladote ® proof of principle study The Scientific Advisory Board for Aladote ® held its first meeting with focus on the design of the next [...]
GENFIT: Third quarter 2018 financial information
23/10/2018
GENFIT: Third quarter 2018 financial information (Unaudited financial information under IFRS) Cash and cash equivalents of €219.9 million at September 30, 2018 Revenues for the first nine months of 2018 of €68 thousand [...]
GENFIT : information financière du troisième trimestre 2018
23/10/2018
GENFIT : information financière du troisième trimestre 2018 (Données non auditées établies selon les normes IFRS) Trésorerie et équivalents de trésorerie s'élevant à 219,9 millions d'euros au 30 septembre 2018 Chiffre d [...]
Alcon to develop SMART Suite digital health platform for cataract surgery
23/10/2018
SMART Suite by Alcon will drive innovation in ophthalmology delivering personalized and seamless end-to-end care for cataract patients As an open, secure cloud-enabled ecosystem, SMART Suite by Alcon will bring greater [...]
Idorsia financial results for the first nine months of 2018
23/10/2018
Allschwil, Switzerland - 23 October 2018 Idorsia Ltd (SIX: IDIA) today announced its financial results for the first nine months of 2018. Jean-Paul Clozel, MD and Chief Executive Officer, commented: "Idorsia continues [...]
Idorsia announces that Simon Jose is to join the company as Chief Commercial Officer
23/10/2018
As Chief Commercial Officer Simon Jose will join the Idorsia Executive Committee Simon's first priority will be to establish a commercial organization Allschwil, Switzerland - October 23, 2018 Idorsia Ltd (SIX: IDIA) [...]
Innate Pharma strengthens and expands its oncology development collaboration with AstraZeneca
23/10/2018
Innate Pharma acquires US and EU rights to commercialize Lumoxiti to become a fully-integrated oncology-focused biotech AstraZeneca obtains full oncology rights to monalizumab AstraZeneca gains access to Innate Pharma's [...]
Innate Pharma renforce et étend sa collaboration de développement en oncologie avec AstraZeneca
23/10/2018
Innate Pharma fait l'acquisition des droits de commercialisation de l'anti-cancéreux Lumoxiti aux Etats-Unis et en Europe, devenant une société de biotechnologies intégrée AstraZeneca acquiert l'intégralité des droits [...]
MDxHealth Provides Business Update for the first nine months of 2018
23/10/2018
NEWS RELEASE REGULATED INFORMATION INTERIM TRADING UPDATE Product and Service revenue up 29% year-on-year IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, October 23, 2018 - MDxHealth SA ("MDxHealth, or the "Company"), ( [...]
MDxHealth (R): MDxHealth publie son rapport d'activités intermédiaire relatif aux neuf premiers mois de 2018
23/10/2018
COMMUNIQUÉ DE PRESSE INFORMATIONS RÉGLEMENTÉES RAPPORT D'ACTIVITÉS INTERMÉDIAIRE Les revenus liés aux produits et services en hausse de 29 % par rapport à l'année précédente IRVINE, CA, et HERSTAL, BELGIQUE - 07h00 CEST [...]

Pages